Prostate-cancer patients who are treated with testosterone-lowering drugs may be twice as likely to develop dementia within five years as those whose testosterone levels are not treated, according to a new study. The research, conducted at the Stanford University School of Medicine and the University of Pennsylvania Perelman School of Medicine, also demonstrates emerging techniques… Continue reading A Prostate-Cancer Treatment May Be Linked to Dementia